Legal & General Group Plc - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 115 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$53,000
-32.1%
998
-22.0%
0.00%
Q2 2020$78,000
+9.9%
1,279
-1.5%
0.00%
Q1 2020$71,000
-22.0%
1,298
-18.4%
0.00%
Q4 2019$91,000
+26.4%
1,591
+17.9%
0.00%
Q3 2019$72,000
-11.1%
1,3490.0%0.00%
Q2 2019$81,000
+8.0%
1,349
+11.4%
0.00%
Q1 2019$75,000
+1.4%
1,2110.0%0.00%
Q4 2018$74,000
+57.4%
1,211
+50.1%
0.00%
Q3 2018$47,000
+11.9%
807
-14.6%
0.00%
Q2 2018$42,000
+2.4%
945
+2.1%
0.00%
Q1 2018$41,000
-31.7%
926
-33.4%
0.00%
Q4 2017$60,000
-20.0%
1,390
-13.0%
0.00%
Q3 2017$75,000
-2.6%
1,597
+2.5%
0.00%
Q2 2017$77,000
-8.3%
1,5580.0%0.00%
Q1 2017$84,000
-2.3%
1,5580.0%0.00%
Q4 2016$86,000
+132.4%
1,558
+90.9%
0.00%
Q3 2016$37,000
-57.0%
816
-62.7%
0.00%
Q2 2016$86,0002,1870.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 211,370$9,833,0005.80%
JW Asset Management, LLC 73,649$3,426,0002.51%
NORTHPOINTE CAPITAL LLC 135,657$6,311,0000.67%
Elk Creek Partners, LLC 170,102$7,913,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 156,167$7,265,0000.32%
Ativo Capital Management LLC 22,592$1,051,0000.28%
Matarin Capital Management, LLC 59,077$2,748,262,0000.23%
ISTHMUS PARTNERS, LLC 16,753$779,0000.22%
CADENCE CAPITAL MANAGEMENT LLC 29,586$1,376,0000.09%
ALGERT GLOBAL LLC 7,834$364,0000.08%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders